COT Statement on hydrolysed cows’ milk formulae

Last updated:
8 March 2016
The COT were asked for their opinion on a systematic review looking at the use of hydrolysed cows’ milk formulae in infants at a high risk of developing atopic outcomes or autoimmune disease. This review will be used to guide the FSA in directing future policy and guidance in this area. This statement summarises the review methodology and authors conclusions as well as the conclusions of the COT.